These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 30052852)

  • 1. New input on antiplatelet treatment and registry studies.
    Agewall S
    Eur Heart J Cardiovasc Pharmacother; 2018 Jul; 4(3):129-130. PubMed ID: 30052852
    [No Abstract]   [Full Text] [Related]  

  • 2. The brave new world of antiplatelet therapy: seeking clarity in a world of increasing choice and complexity.
    Price MJ
    Rev Cardiovasc Med; 2011; 12 Suppl 1():S1-3. PubMed ID: 22080982
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Paving the way for improved antiplatelet therapy.
    Grove EL
    Curr Pharm Des; 2012; 18(33):5195-6. PubMed ID: 22724421
    [No Abstract]   [Full Text] [Related]  

  • 4. Antiplatelet medications: old and emerging therapies.
    Stone WM; Naidu SG; Chapital A; Money SR
    Ann Vasc Surg; 2010 Jan; 24(1):140-8. PubMed ID: 19619976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet agents: current drugs and future trends.
    Messmore HL; Jeske WP; Wehrmacher W; Coyne E; Mobarhan S; Cho L; Leya FS; Moran JF
    Hematol Oncol Clin North Am; 2005 Feb; 19(1):87-117, vi. PubMed ID: 15639110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of P2Y12 inhibitors according to diabetes, age, gender, body mass index and body weight: systematic review and meta-analyses of randomized clinical trials.
    Zaccardi F; Pitocco D; Willeit P; Laukkanen JA
    Atherosclerosis; 2015 Jun; 240(2):439-45. PubMed ID: 25897998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet reactivity tests for assessing antiplatelet drug response: what the clinician needs to know.
    Steiner S; Moertl D
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):975-84. PubMed ID: 23984925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.
    Tangelder MJ; van Hattum ES
    Thromb Haemost; 2010 Aug; 104(2):196-9. PubMed ID: 20508897
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacogenetics of antiplatelet therapy: ready for clinical application?
    Verschuren JJ; Jukema JW
    Heart; 2011 Aug; 97(15):1268-76. PubMed ID: 21742619
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiplatelet agents in hemodialysis.
    Migliori M; Cantaluppi V; Scatena A; Panichi V
    J Nephrol; 2017 Jun; 30(3):373-383. PubMed ID: 27928736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiplatelet and anticoagulants drugs.
    Treat Guidel Med Lett; 2008 May; 6(69):29-36; quiz 2 p following 36. PubMed ID: 18443541
    [No Abstract]   [Full Text] [Related]  

  • 12. Cell-derived microvesicles in cardiovascular diseases and antiplatelet therapy monitoring - A lesson for future trials? Current evidence, recent progresses and perspectives of clinical application.
    Tomaniak M; Gąsecka A; Filipiak KJ
    Int J Cardiol; 2017 Jan; 226():93-102. PubMed ID: 27792994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [What have we learned from the expert consensus of antiplatelet therapy in cardiovascular disease?].
    Huo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Mar; 41(3):179-80. PubMed ID: 23879939
    [No Abstract]   [Full Text] [Related]  

  • 14. No reduction in cardiovascular risk with NSAIDs-including aspirin?
    Cleland JG
    Lancet; 2002 Jan; 359(9301):92-3. PubMed ID: 11809245
    [No Abstract]   [Full Text] [Related]  

  • 15. The use of antiplatelet agents in cardiac disease.
    Tepper D; Ip RJ; Ip JH
    Manag Care Interface; 2000 May; 13(5):76-8. PubMed ID: 11067401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic basis of individual sensitivity to antiplatelet drugs].
    Kudriashov OIu; Zateĭshchikov DA; Sidorenko BA
    Kardiologiia; 2005; 45(9):85-9. PubMed ID: 16234800
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease.
    Wang TY; Angiolillo DJ; Cushman M; Sabatine MS; Bray PF; Smyth SS; Dauerman HL; French PA; Becker RC
    J Am Coll Cardiol; 2012 Mar; 59(10):891-900. PubMed ID: 22381424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet therapy to prevent cardiovascular events and mortality in patients with intermittent claudication.
    Wong PF; Chong LY; Stansby G
    JAMA; 2013 Mar; 309(9):926-7. PubMed ID: 23462789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term use of oral antiplatelet therapy: from studies to practice].
    Helft G
    Presse Med; 2010 Apr; 39(4):413-9. PubMed ID: 19880273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Strategies to Reduce Gastrointestinal Bleeding Risk Associated with Antiplatelet Agents.
    Parekh PJ; Oldfield EC; Johnson DA
    Drugs; 2015 Sep; 75(14):1613-25. PubMed ID: 26330139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.